ESR1 and breast cancer: The power to detect the odds ratio of 1.2 (or equally 0.80) was > 99% for RHOD in overall, ER+ and ER− breast cancer using eQTL obtained from breast tissue and ≥ 30% using eQTL obtained from blood (Table 1).